GB0911770D0 - Antibody - Google Patents
AntibodyInfo
- Publication number
- GB0911770D0 GB0911770D0 GBGB0911770.6A GB0911770A GB0911770D0 GB 0911770 D0 GB0911770 D0 GB 0911770D0 GB 0911770 A GB0911770 A GB 0911770A GB 0911770 D0 GB0911770 D0 GB 0911770D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/193—Equine encephalomyelitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0812316.8A GB0812316D0 (en) | 2008-07-07 | 2008-07-07 | Antibody |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0911770D0 true GB0911770D0 (en) | 2009-08-19 |
GB2461635A GB2461635A (en) | 2010-01-13 |
Family
ID=39718019
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0812316.8A Ceased GB0812316D0 (en) | 2008-07-07 | 2008-07-07 | Antibody |
GB0911770A Withdrawn GB2461635A (en) | 2008-07-07 | 2009-07-07 | Functional antibody fragments which bind multiple Venezuelan equine encephalitis virus strains |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0812316.8A Ceased GB0812316D0 (en) | 2008-07-07 | 2008-07-07 | Antibody |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB0812316D0 (en) |
WO (1) | WO2010004276A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2496854A (en) * | 2011-11-22 | 2013-05-29 | Secr Defence | Anti-VEEV antibodies and their use in prophylaxis or treatment |
US20230065377A1 (en) * | 2019-08-31 | 2023-03-02 | Vanderbilt University | Human antibodies to alphaviruses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2374027A1 (en) * | 2001-03-13 | 2002-09-13 | The Minister Of National Defence | Cloning, expression, sequencing, and functional enhancement of monoclonal scfv antibody against venezuelan equine encephalitis virus(vee) |
US20040009178A1 (en) * | 2002-02-11 | 2004-01-15 | Bowdish Katherine S. | Immunotherapeutics for biodefense |
US20040258699A1 (en) * | 2002-02-11 | 2004-12-23 | Bowdish Katherine S. | Immunotherapeutics for biodefense |
CA2420829A1 (en) * | 2002-03-06 | 2003-09-06 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Novel fusion protein of human igg1 heavy chain constant region and scfv antibody against venezuelan equine encephalitis virus |
JP2005532825A (en) * | 2002-05-13 | 2005-11-04 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | Humanized antibodies against Venezuelan equine encephalitis virus |
CA2462343A1 (en) * | 2003-03-25 | 2004-09-25 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Genetically biotinylated recombinant antibody in immunofiltration assay by light addressable potentiometric sensor for identification of venezuelan equine encephalitis virus |
-
2008
- 2008-07-07 GB GBGB0812316.8A patent/GB0812316D0/en not_active Ceased
-
2009
- 2009-07-07 WO PCT/GB2009/001693 patent/WO2010004276A2/en active Application Filing
- 2009-07-07 GB GB0911770A patent/GB2461635A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2010004276A3 (en) | 2010-04-29 |
GB0812316D0 (en) | 2008-08-13 |
WO2010004276A2 (en) | 2010-01-14 |
GB2461635A (en) | 2010-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2241578A4 (en) | Anti-cldn6 antibody | |
ZA201102119B (en) | Improved antibody libraies | |
GB0708002D0 (en) | Antibodies | |
HK1136970A1 (en) | Penta-specific antibody | |
GB0821100D0 (en) | Antibodies | |
ZA201104545B (en) | Anti-siglec-15 antibody | |
EP2138576A4 (en) | Anti-claudin-4 antibody | |
IL214996A0 (en) | Anti-bcma antibodies | |
GB0920127D0 (en) | Antibodies | |
GB0909906D0 (en) | Antibodies | |
EP2337798A4 (en) | Bsa-specific antibodies | |
EP2172483A4 (en) | ANTI-Muc17 ANTIBODY | |
EP2427496A4 (en) | Anti-vegf-d antibodies | |
IL205073A0 (en) | Anti-bst2 antibody | |
GB0718737D0 (en) | Antibodies | |
ZA201006099B (en) | Anti-tyrp1 antibodies | |
GB0920324D0 (en) | Antibodies | |
HK1170745A1 (en) | Antibodies against il-17br il-17br | |
ZA201007976B (en) | Anti-pirb antibodies | |
GB0818356D0 (en) | Antibodies | |
GB2473934B (en) | Anti-VEEV antibody | |
EP2499256A4 (en) | Anti-c-mpl antibodies | |
EP2424892A4 (en) | Dc-stamp antibodies | |
GB0911770D0 (en) | Antibody | |
EP2264071A4 (en) | Antibody having an immune-enhancement function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |